NIOX Group (LON:NIOX) Shares Up 1.8% – Here’s What Happened

NIOX Group Plc (LON:NIOXGet Free Report)’s stock price was up 1.8% during trading on Friday . The company traded as high as GBX 67.60 and last traded at GBX 67.20. 1,067,430 shares traded hands during trading, an increase of 31% from the average daily volume of 816,665 shares. The stock had previously closed at GBX 66.

NIOX Group Trading Up 1.8%

The company has a quick ratio of 1.94, a current ratio of 3.81 and a debt-to-equity ratio of 1.36. The company has a market cap of £282.82 million, a P/E ratio of 40.98 and a beta of 0.92. The firm’s 50 day moving average is GBX 64.44 and its two-hundred day moving average is GBX 61.42.

About NIOX Group

(Get Free Report)

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.

Further Reading

Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.